Counseling in Inflammatory Bowel Diseases: A Question, an Observation, and a Proposal

Affiliations

Comment

Rinaldo Pellicano. Turk J Gastroenterol. 2022 Feb.

. 2022 Feb;33(2):168.

doi: 10.5152/tjg.2022.201133.

No abstract available

Conflict of interest statement

Conflict of Interest: The author have no conflict of interest to declare.

The specialized educational and psychological counseling in inflammatory bowel disease patients - a target or a challenge?
Gavrilescu O, Prelipcean CC, Dranga M, Soponaru C, Mihai C. Gavrilescu O, et al. Turk J Gastroenterol. 2020 Nov;31(11):760-766. doi: 10.5152/tjg.2020.19669. Turk J Gastroenterol. 2020. PMID: 33361038 Free PMC article. Clinical Trial.

1. Gavrilescu O, Prelipcean CC, Dranga M, Soponaru C, Mihai C. The specialized educational and psychological counseling in inflammatory bowel disease patients: a target or a challenge. Turk J Gastroenterol. 2020;31(11):760 766. 10.5152/tjg.2020.19669) - DOI - PMC - PubMed
1. Pugliese D, Privitera G, Pizzolante F, Gasbarrini A, Guidi L, Armuzzi A. Therapeutic drug monitoring with vedolizumab in inflammatory bowel disease. Minerva Gastroenterol Dietol. 2019;65(4):280 290. 10.23736/S1121-421X.19.02625-4) - DOI - PubMed
1. Ribaldone DG, Vernero M, Saracco GM, et al. The adherence to the therapy in inflammatory bowel disease: beyond the number of the tablets. Scand J Gastroenterol. 2018;53(2):141 146. 10.1080/00365521.2017.1405070) - DOI - PubMed